Abstract
There are many nanoencapsulation systems available today. Among all these, mesoporous silica particles (MSPs) have received great attention in the last few years. Their large surface-to-volume ratio, biocompatibility, and versatility allow the encapsulation of a wide variety of drugs inside their pores. However, their chemical instability in biological fluids is a handicap to program the precise release of the therapeutic compounds. Taking advantage of the dissolving capacity of silica, in this study, we generate hollow capsules using MSPs as transitory sacrificial templates. We show how, upon MSP coating with different polyelectrolytes or proteins, fully customized hollow shells can be produced. These capsules are biocompatible, flexible, and biodegradable, and can be decorated with nanoparticles or carbon nanotubes to endow the systems with supplementary intrinsic properties. We also fill the capsules with a fluorescent dye to demonstrate intracellular compound release. Finally, we document how fluorescent polymeric capsules are engulfed by cells, releasing their encapsulated agent during the first 96 h. In summary, here, we describe how to assemble a highly versatile encapsulation structure based on silica mesoporous cores that are completely removed from the final polymeric capsule system. These drug encapsulation systems are highly customizable and have great versatility as they can be made using silica cores of different sizes and multiple coatings. This provides capsules with unique programmable attributes that are fully customizable according to the specific needs of each disease or target tissue for the development of nanocarriers in personalized medicine.
Highlights
Many drugs of extraordinary pharmacological interest have been discarded because of their untargeted toxicity or premature degradation
Both phosphate-buffered saline (PBS) and BSS are typical isotonic buffered solutions commonly used in cellular nanocarrier experiments
Silica dissolution is affected by the intrinsic properties of the paInrtt.icJ.leMo[2l.8S,c3i.82]0.2I0n, 2p1,a9r5t7ic3ular, we observed (i) the size of the particle, (ii) the size of the mesopor3eosf,13 and (iii) the silica density
Summary
Many drugs of extraordinary pharmacological interest have been discarded because of their untargeted toxicity or premature degradation. Therapeutic compound encapsulation in nanocarriers is an excellent alternative to traditional formulations It can help poorly soluble or labile therapeutic compounds to achieve potent therapeutic effects at their target site, minimizing the drug’s side effects and toxicity issues, while significantly improving the drug’s biodistribution or stability. Mesoporous silica particles (MSPs) have attracted much attention thanks to their singular properties: they are biocompatible; safe; and display a versatile, customizable, and controllable nature [13,14] These nanomaterials exhibit modifiable surface properties, a huge surface-to-weight ratio (700–1000 m2/g) [15,16] with a well-defined internal mesopore structure (from 2 to 10 nm of diameter), and a large pore volume (0.6–1 cm3/g) [17]; they can be adapted to carry many different bioactive molecules
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.